In this article (Clin Cancer Res 2016;22:1432–44), which was published in the March 15, 2016, issue of Clinical Cancer Research (1), the name of the Skip Viragh Foundation was misspelled in the published Grant Support section. The full, corrected version is below. The authors regret this error.

This research was supported in part by grants from the NCI (CA 097109 and CA 109405, to P.J. Chiao), the Skip Viragh Foundation (to P.J. Chiao), and a Cancer Center Support grant to MD Anderson (CA16672).

1.
Zhuang
Z
,
Ju
H
,
Aguilar
M
,
Gocho
T
,
Li
H
,
Iida
T
, et al
IL1 receptor antagonist inhibits pancreatic cancer growth by abrogating NF-κB activation
.
Clin Cancer Res
2016
;
22
:
1432
44
.